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Objective: The induction of synovial tissue to the meniscal lesion is crucial for meniscal healing. Synovial
Mesenchymal stem cells (MSCs) are an attractive cell source because of their high proliferative and
chondrogenic potentials. We examined whether transplantation of synovial MSCs promoted healing after
meniscal repair of extended longitudinal tear of avascular area in a microminipig model.
Design: Longitudinal tear lesion was made in medial menisci and sutured in both knees, and then a
synovial MSC suspension was administered for 10 min only in unilateral knee. The sutured meniscus was
evaluated morphologically and biomechanically at 2, 4, and 12 weeks. The behavior of transplanted MSCs
was also examined.
Results: The meniscal healing at 12 weeks was signiﬁcantly better in the MSC group than in the control
group; macroscopically, histologically and by T1rho mapping analysis. Transmission electron microscopic
analysis demonstrated that the meniscus lesion was occupied by dense collagen ﬁbrils only in the MSC
group. Biomechanical analysis revealed that the tensile strength to failure of the meniscus higher in the
MSC group than in the control group in each microminipig. Synovial tissue covered better along the
superﬁcial layer from the outer zone into the lesion of the meniscus in the MSC group at 2 and 4 weeks in
each microminipig. Synovial MSCs labeled with ferucarbotran were detected in the meniscus lesion and
adjacent synovium by MRI at 2 weeks.
Conclusion: Transplantation of synovial MSCs promoted healing after meniscal repair with induction of
synovium into the longitudinal tear in the avascular zone of meniscus in pigs.
© 2015 The Authors. Published by Elsevier Ltd and Osteoarthritis Research Society International. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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Meniscus injuries are a common cause of knee dysfunction, and
surgical treatment for meniscus injury is one of the most frequent
orthopedic operative procedures1. Since a meniscectomy increases
the risk of osteoarthritis2,3, a meniscal suture repair is recom-
mended as a ﬁrst choice surgery for meniscus tear. However,
meniscal suture repair is generally limited only to the vascular area
and even for the vascular area, failure rate after suture repair is
about 30%4,5. New procedures to widen the indication for meniscal
suture repair, to improve outcomes, are required.
The induction of synovial tissue to the meniscal lesion will be
crucial for meniscal healing. Indeed, King reported approximatelyociety International. This is an open access article under the CC BY-NC-ND license
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communicated with the synovium and capsule6. Unfortunately, the
reparative potential of synovium for meniscus lesion is limited, and
therefore, spontaneous repair of the injured meniscus in the
avascular zone cannot be usually expected. To promote this process,
several methods are attempted such as supplementation with sy-
novial ﬂaps7, synovial grafts8 and induction of synovium by rasp-
ing9. However, these techniques are not common practice at
present due to the difﬁculty in performing the procedures and lack
of efﬁcacious outcomes. Novel applications using synovium are
expected to be developed to improve the outcome of meniscus
repair.
Mesenchymal stem cells (MSCs), which can be isolated from
synovium10, are attractive for meniscus repair because synovial
MSCs have a high proliferative and chondrogenic potential11e14.
Intraarticular injection of synovial MSCs promoted meniscus
regeneration after the anterior half of the medial meniscus was
resected in rats15, rabbits16, and pigs17. MSCs in the synovial ﬂuid of
the knee increased in number after meniscus injury18 and charac-
teristics of MSCs in synovial ﬂuid were close to synovial MSCs19,20,
indicating a physiological role of synovial MSCs during meniscal
healing in the natural course. In this study, we examined whether
transplantation of synovial MSCs promoted healing after meniscal
repair in a pig model that was closer to human clinical pathology
than the anterior half meniscal defect model we previously
examined. This method broaden its indication for meniscal suture
repair with promising outcomes.
Materials and methods
Animals
All experiments were conducted in accordance with the insti-
tutional guidelines for the care and use of experimental animals at
Tokyo Medical and Dental University. Twelve-month-old, skeletally
mature microminipigs21 (Fujimicra Corp, Shizuoka, Japan) were
used. The average weight was 13 kg. Synovial MSCs from three
microminipigs were prepared and their colony forming abilities
were examined. Synovial MSCs with highest colony forming ability
were chosen as donor MSCs. One transgenic microminipig ubiqui-
tously expressing green ﬂuorescent protein (GFP) was also used to
prepare GFPþ synovial MSCs for cell tracking. This GFPþ micro-
minipig was developed by hybridizing GFP transgenic Jinhua pigs22
and wild type microminipigs. Seventeen microminipigs were used
as recipients but two were excluded because of postoperative
complications; death just after surgery and wound infection in the
control side at 2 weeks. Therefore, ﬁfteen microminipigs were
analyzed; four microminipigs were evaluated at 2 weeks after
transplantation, four microminipigs at 4 weeks, ﬁve microminipigs
at 12 weeks, and two microminipigs for GFP observation.
Cell isolation and culture
Synovium harvested through an arthrotomy of the knee was
digested with 3 mg/ml Collagenase D (Roche Diagnostics, Man-
nheim, Germany) for 3 h, and cultured at a clonal density in com-
plete culture medium (CCM): aMEM (Invitrogen, Carlsbad, CA)
containing 10% fetal bovine serum for 14 days23.
Characterization experiments
To characterize cells derived from the synovium of micro-
minipigs asMSCs, we performed colony forming unit assays, in vitro
differentiation assays, and examined surface markers, as described
previously23e28.Surgical procedures
Under general anesthesia, both knees were operated on at the
same time, in each animal. One kneewas assigned to theMSC group
and the other to the control group. Each knee was approached
through a medial parapatellar arthrotomy. To expose a whole
medial meniscus, the medial collateral ligament was cut and the
knee was maximally ﬂexed and externally rotated. A full-thickness
longitudinal tear was created in the junction between the internal
third and middle third of the meniscus in the avascular area from
the anterior to the posterior portion with use of a 1.0 mm diameter
biopsy punch (Kai Corp, Tokyo, Japan). The tear was repaired by
mattress suture using 4-0 nylon (Bear Medical Corp, Chiba, Japan).
For transplantation of synovial MSCs, with the tibial joint surface
facing upward, 2  107 synovial MSCs at passage two suspended in
100 ml of glucose-added, acetic acid maintenance infusion solution
(Veen-3G inj, Kowa Corp, Tokyo, Japan) were placed directly into
themeniscal lesionwith use of a 23-gauge needle. Knees were then
held stationary for 10min. In the control knees, the same volume of
solution without cells was placed as a control, and the knees were
once again held stationary for 10 min. The medial collateral liga-
ment, capsule, and skin were closed in layers with non-absorbable
sutures. The microminipigs were allowed to move freely in their
cages without any ﬁxation method.
Macroscopic observation
The medial menisci were photographed using an Olympus
MVX10 stereoscopic microscope (Olympus Corp, Tokyo, Japan). The
macroscopic features were scored on a modiﬁed scoring system
based on that developed by Ruiz-Iban et al29. The lesionwas divided
into anterior, middle, and posterior parts. The score was calculated
by summing up the scores from 0 to 3 of each of the three parts.
Consequently, the ﬁnal scores were between 0 and 9 points
(Supplemental Table 1).
Histological analysis
Sections at 5 mm were stained with toluidine blue, picrosirius
red (Picrosirius red Stain Kit, Polysciences, Inc., Warrington, PA), or
hematoxylin & eosin (HE). Histological pictures were taken by light
microscopy (Olympus IX71). The histology was scored on a modi-
ﬁed scoring system based on that developed by Zellner et al30. The
repair was graded by summing up the scores from 0 to 3 of 6 in-
dividual subgroups. Consequently, the ﬁnal scores were between
0 points (no repair) and maximal 18 points (complete reconstitu-
tion of the meniscus) (Supplemental Table 2). To quantify the in-
duction of synovial tissue to the lesion, an original score was used
(Supplemental Table 3). These scores were evaluated by two in-
dependent observers in a blinded manner. Picrosirius red stained
sections were observed with a polarizing microscope (Olympus
BX51). To evaluate picrosirius red positive areas in the lesion, bright
diffracted light areas were measured using Image J software (Na-
tional Institutes of Health, Bethesda, MD)31.
Immunohistochemistry
Type I and II collagen was visualized using diaminobenzidine
staining. For type II collagen, a rabbit polyclonal antibody (ab34172,
Abcam) and for type I collagen, a mouse monoclonal antibody
(ab90395, Abcam, Cambridge, UK) was used17. For Ki67, a rabbit
polyclonal antibody (NB500-170, Novus Biologicals, Littleton, CO),
and species-speciﬁc AlexaFluor-555 conjugated secondary anti-
body were used.
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The specimens were ﬁxed in 2.5% glutaraldehyde in 0.1M
phosphate buffer for 2 h. The samples were washed with 0.1M
phosphate buffer, post-ﬁxed in 1% OsO4 buffered with 0.1M phos-
phate buffer for 2 h, dehydrated in a graded series of ethanol and
embedded in Epon 812. Ultrathin sections at 90 nmwere collected
on copper grids, double-stained with uranyl acetate and lead cit-
rate, and then examined with a transmission electron microscope
(H-7100, Hitachi, Tokyo, Japan)32.
MRI for T1rho mapping
After sacriﬁce, the knee joints were removed and examined by
MRI 3.0 T imager (Achieva; Philips Medical Systems, Andover, MA).
The knee joint was set up in the coils for the wrist MRI (Phillips
Medical System). The sagittal T1rho mapping was analyzed with
Ziostation2 software (Ziosoft, Inc., Tokyo, Japan) for the T1rho
mapping. The region of interest was set manually. Parameters are
listed in Supplemental Table 4.
Biomechanical analysis
After removal of suture threads, the meniscus was divided into
three parts; an anterior, middle and posterior part. The anterior and
posterior parts were used for the biomechanical analysis, and the
middle part was used for histological analysis. The specimen was
set on a mechanical testing frame (Autograph, Shimadzu Corp,
Kyoto, Japan). One edge of themeniscus was held tightly with a vice
grip (SC-3, Imada Corp, Aichi, Japan) and the other edge was held
with a small chuck (PGC, Imada Corp). The specimenwas then split
across the repair tissue with a deﬁned crosshead speed of 1 mm/
min. The force needed to separate the meniscus in the area of the
repair was recorded. Then, the cross-sectional area of the repaired
tissue was measured using a stereoscopic microscope (Olympus
MVX10), and the tensile strength at failure was calculated. The
average value for failure strength of the anterior and posterior parts
was calculated. Intact meniscus was also examined.
Cell tracking for GFPþ MSCs
To examine whether transplanted cells adhered to the meniscus
lesion, GFPþ microminipig synovial MSCs were transplanted into
two knee joints of two microminipigs. After 1  107 GFPþ MSCs at
passage three were transplanted and the skin was closed, the knee
was ﬂexed and extended 100 times, and then the meniscus with
tibial plateau was photographed using a stereoscopic microscope
(Olympus MVX10).
Cell tracking for synovial MSCs labeled with ferucarbotran by MRI
For this assay only, synovial MSCs at passage two were cultured
with ferucarbotran (Resovist, Bayer Schering Pharma, Leverkusen,
Germany) which is a superparamagnetic iron oxide, at a ﬁnal
concentration of 100 mg/mL for 1 day. Two weeks after trans-
plantation, the knee joints were examined by MRI 3.0 T imager
(Achieva). Parameters are listed in Supplemental Table 4. Only
these two pigs received ferucarbotran MSCs.
Statistical methods
Comparisons between the MSC group and the control group
were analyzed using the Wilcoxon's signed rank test. P value was
calculated, except cases inwhich sample number was less than ﬁve.
P value of <0.05 was considered statistically signiﬁcant.Additional methods
Detailed methods for characterization of cells and immunohis-
tochemistry are described in Supplemental Methods.
Results
Synovial cells from a microminipig had characteristics of MSCs
Cells derived from the synovium of microminipigs were colony-
forming (Fig. 1A). These cells differentiated into chondrocytes, ad-
ipocytes and mineralized tissue (Fig. 1A). Flow cytometric analysis
demonstrated that the majority of these cells expressed CD90,
CD44, and CD105, and were negative for CD11b, and CD45 (Fig. 1B).
Transplanted synovial MSCs promoted healing after meniscal repair
For this procedure, a longitudinal tear was created in the avas-
cular area, then a suspension containing synovial MSCs was placed
on the sutured meniscus (Fig. 1C). Menisci were graded on the
progress of repair in three parts (anterior, middle, and posterior) by
macroscopic examination (Fig. 2A). At 2 weeks, the MSC group had
undergone partial repair of at least two parts and partial repair of
three parts in one case (Fig. 2B). In the control group, menisci were
partially repaired in only one part, with the exception of one case in
which no healing was observed at all. In the MSC group at 4 weeks,
complete healing at two or three parts was observed in three cases,
with at least partial repair in all parts in all cases. In the control
group, menisci repair was much less robust in all cases, with no
healing at all for two parts observed in two cases. In the MSC group
at 12 weeks, complete healing at three parts was observed in the
best case, and partial healing at three parts was observed in the
worst case. In the control group, no healing in at least one part was
still observed in two cases. Macro scores for meniscus healing
(Supplemental Table 1) were higher in the MSC group than in the
control group in each microminipig at 2, 4 and 12 weeks (Fig. 2B).
Histologically, in the MSC group at 2 weeks, the lesion was
partially connected in all cases (Fig. 3A). The lesions were ﬁlledwith
a large number of polygonal, spindle shape cells, or acellular matrix.
In the control group, the lesion was partially connected in only one
case. In the MSCs group at 4 weeks, the lesion appeared to be
connected more tightly as in the representative case. In the control
group, the lesion was still connected partially in all cases. At 12
weeks, in the MSC group, the lesion appeared to be fully connected
and/or healed completely even in the worst case. The lesion also
became closer to the adjacent normal meniscus in terms of meta-
chromasia and cell morphology. In the control group, the lesionwas
still connected partially in all cases. Histological scores for meniscus
healing (Supplemental Table 2) were higher in the MSC group than
in the control group in each microminipig at 2, 4 and 12 weeks
(Fig. 3B). At 12 weeks, the MSC group expressed more type II
collagen, both in punctuate small foci and dispersed throughout.
Type I Collagen was diffusely present in both MSC and control
groups (Fig. 3C). To examine collagen ﬁber volume and organiza-
tion in the lesion, sections were stained with picrosirius red and
observed under polarized microscopy (Fig. 3D). Though the pic-
rosirius red positive area in the lesion increased with time in both
groups, the picrosirius red positive area ratio in the lesion was
higher in the MSC group than in the control group in each micro-
minipig at 2, 4, and 12 weeks (Fig. 3E).
Transmission electron microscopic analysis demonstrated that
the lesion in the MSC group at 12 weeks was occupied by dense
collagen ﬁbrils with smaller diameter than those observed in an
intact meniscus (Fig. 3F). Contrarily, in the control group, organized
collagen ﬁbrils were not observed in the lesion.
Fig. 1. Characteristics of cells from microminipig synovium and experimental set up. (A) Representative images for colony formation and multilineage differentiation of synovial
MSCs. (B) Epitope proﬁle. (C) Procedure. (i) After exposing the medial meniscus, a longitudinal tear (indicated with black arrows) was created from the anterior to posterior segment
using a skin biopsy punch with a diameter of 1 mm (ii) Instability of the meniscus was conﬁrmed. (iii) Meniscus was sutured with nylon thread (indicated with white arrows). (iv)
Synovial MSC suspension was placed on the sutured meniscus. (v) The sutured meniscus was immersed in a synovial MSC suspension for 10 min (vi) The anterior and medial
capsule was closed. MM, medial meniscus; MFC, medial femoral condyle; P, patella.
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inner area of the lesion in the control group at 12 weeks were
higher than in the MSC group (Fig. 3G). T1rho values in the MSC
group were signiﬁcantly lower than in the control group, showing
T1rho values in the MSC group were closer to that of the intact
meniscus than in the control group (Fig. 3H).
Synovial MSCs promoted induction and formation of synovial tissue
in the lesion
We also evaluated the induction of synovial tissue into the
meniscus lesion. In the MSC group, synovial tissue already covered
the lesion along the superﬁcial layer of the meniscus from the outer
zone down into the lesion in the inner zone at 2 weeks, covered an
even wider area around the lesion at 4 weeks, and increasedcoverage even further at 12 weeks (Fig. 4A). Contrarily, in the
control group, synovial tissue did not reach the lesion at 2 and 4
weeks, until ﬁnally reaching at 12 weeks. Synovial coverage scores
for meniscus healing (Supplemental Table 3) were higher in the
MSC group than in the control group in each microminipig at 2 and
4 weeks (Fig. 4B). In the MSC group, the lesion was still covered
with synovium but the synovial cell layer decreased at 12 weeks.
To analyze proliferation of the cells in the synovial tissue that
were induced into the meniscal lesion, the expression of Ki-67, a
proliferation marker, was examined. At 4 weeks, there were many
Ki-67 positive cells in the MSC group, but only a few in the control
group (Fig. 4C).
Transmission electron microscopic observation demonstrated a
great number of spindle-shaped or polygonal cells around the
lesion at the superﬁcial layer in the MSC group at 4 weeks. This
Fig. 2. Macroscopic analysis. (A) Macroscopic features. To remove individual variability, the menisci in the MSC and control groups of the same pig are shown in the same row. For
“Best”, “Representative”, and “Worst”, each case in the MSC group was selected. In some pictures, the forceps were used to pull at the inner side of the meniscus in order to display
the lesion. (B) Quantiﬁcation of macroscopic ﬁndings evaluated by modiﬁed Miguel's scoring system29 (Supplemental Table 1). P value was calculated byWilcoxon's signed rank test
except cases in which sample number was less than ﬁve.
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Contrarily, only a few cells were observed around the lesion in the
control group.
Synovial MSCs increased tensile strength at failure of the meniscus
For biomechanical analysis (Fig. 5A), the average tensile strength
at failure was 10.5 N/mm2 in the MSC group, 4.6 N/mm2 in the
control group, and 20.8 N/mm2 in the intact meniscus. The failure
occurred where the lesion was ﬁrst made in all cases. The tensile
strength at failure of the meniscus was higher in the MSC group
than in the control group in each microminipig (Fig. 5B).
Transplanted synovial MSCs located around the lesion and adjacent
synovium
GFPþ cells were observed in the lesion and synovium around
the lesion 10 min after synovial MSC suspension was added to
the lesion. This ﬁnding was observed in each of the two
microminipigs tested (Fig. 6A). Most synovial MSCs took upparticles of ferucarbotran 24 h after incubation (Fig. 6B). Fer-
ucarbotran can be visualized as scattered black dots in MRI. Two
weeks after the transplantation of synovial MSCs, particles of
ferucarbotran were observed around the lesions and anterior
synovium (Fig. 6C).Discussion
We were able to demonstrate that both macro and histological
scores for meniscus healing were higher in the MSC group than in
the control group in a longitudinal meniscal repair model in each
microminipig. T1rho values in the MSC group were closer to that of
intact meniscus than in the control group. The tensile strength at
failure of the meniscus was higher in the MSC group than in the
control group in each microminipig at 12 weeks. Transplantation of
synovial MSCs was able to promote healing of repaired meniscus.
MRI provides a useful tool to examine healing after meniscal
repair. In this study, we employed T1rho mapping to evaluate the
quality of the repaired meniscus. In articular cartilage, T1rho
Fig. 3. Histological analysis. (A) Histological sections stained with toluidine blue for the meniscal lesions. Lesions are indicated with black arrows. For “Best”, “Representative”, and
“Worst”, each case in the MSC group was selected. (B) Quantiﬁcation of histology evaluated by modiﬁed Zeller's scoring system30 (Supplemental Table 2). P value was calculated by
Wilcoxon’s signed rank test. (C) Histological sections immunostained with type II and type I collagen. The lesions are indicated with arrows. (D) Histological sections stained with
picrosirius red under polarized microscope. The lesions are indicated with arrows. Borders between the lesion and the normal area are indicated with dotted line. (E) Quantiﬁcation
of picrosirius red positive area ratio in the lesion. P value was calculated by Wilcoxon's signed rank test. (F) Transmission electron microscopic images of collagen ﬁber architecture
in the lesions both in the MSC group and the control group at 4 weeks, and the same area in an intact meniscus. (G) Representative T1rho mapping images with color bar. Lesions are
indicated with white arrows. (H) T1rho values of injured medial meniscus and intact meniscus. P value was calculated by Wilcoxon's signed rank test.
Y. Nakagawa et al. / Osteoarthritis and Cartilage 23 (2015) 1007e10171012mapping has been shown to evaluate glycosaminoglycan (GAG)
concentration33.
Transplanted allogeneic MSCs could provide two mechanisms
for meniscal healing. Firstly, MSCs have the differentiation potential
to go to meniscal cells. According to our previous study, LacZþsynovial MSCs could be observed in the regenerated meniscus 12
weeks after transplantation in a rat model15. Secondly, MSCs pro-
duce a wide variety of cytokines and other trophic support factors.
Our species speciﬁc microarray analyses showed that synovial
MSCs increased the gene expression of hundreds of genes including
Fig. 3. (continued).
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osteoarthritis model (in submission). The current study revealed
that one of the important cytokine effects caused by synovial MSCs
was the induction of synovial tissue to the meniscal lesion or the
formation of synovial tissue in the meniscal lesion. A number of
papers have provided support for the importance of this induction
of synovial tissue to the meniscal lesion for meniscal healing7,8.
Synovium induced into the meniscal lesion had a large number
of Ki67 positive, proliferating cells at 4 weeks. The lesion was still
covered with synovium but the synovial cell layer was decreased at
12 weeks possibly because the initial proliferative phase transi-
tioned to the remodeling phase in the induced synovium.
Biomechanical testing is an important evaluation analytic for
functional meniscal repair. There are several methods that have
been employed to various experimental models30,34e36. We divided
the meniscus into three parts, the anterior and posterior parts were
used for biomechanical testing, and the average values for thetensile strength at failure was calculated. This method is similar to
reports by Pabbruwe et al36. The remaining middle part was used
for histological analysis. With this method, we could perform both
biomechanical and histological analyses on the same meniscus in
order to reduce the additional animals used in the experiment.
In this study, we transplanted 20 million cells per meniscus.
We previously reported that intraarticular injections of 50 million
allogeneic synovial MSCs promoted meniscus regeneration in a
massive meniscal defect model using minipigs17. The averaged
body weight of microminipigs used in this experiment was
approximately 13 kg and that of minipigs used in our previous
report was approximately 32 kg. We scaled the dosage of cells
with body weight (40%) between the two strains.
To track the synovial MSCs, we used GFPþ synovial MSCs, which
were observed in the lesion and synovium around the lesion 10min
after the synovial MSC suspension was immersed on the lesion. To
track synovial MSCs by MRI, we used synovial MSCs labeled with
Fig. 4. Analysis for induction and formation of synovial tissue from the outer zone to the lesion of the meniscus. (A) Histological sections stained with hematoxylin and eosin for the
femoral side of the meniscal lesions. Continuous synovial tissues from outer zone going to lesion in the inner zone are indicated with dotted arrows. Lesions are indicated with black
arrows. In the insets, synovial tissues covering meniscus are indicated with black bars. (B) Quantiﬁcation of histology for synovial coverage (Supplemental Table 3). P value was
calculated by Wilcoxon's signed rank test. (C) Histological sections stained with Ki67. The lesions are indicated with a black arrow head. Ki67 positive cells are indicated with white
arrows. (D) Transmission electron microscopic images of the surface in the lesion both in the MSC group and the control group at 4 weeks, and synovium in an intact meniscus.
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observed around the lesions and anterior synovium 2 weeks after
transplantation. We previously reported that more than 60% of
synovial MSCs suspended in phosphate buffered saline (PBS) placedupon an osteochondral defect adhered to the defect in 10min38 and
ultimately promoted cartilage regeneration23 and the addition of
magnesium in the cell suspension enhanced this adherence
through the activation of integrins39. In this study we suspended
Fig. 5. Biomechanical analysis (A) Mechanical testing frame and vice grip. Meniscus is
indicated with an arrow. (B) Tensile strength at failure for injured meniscus and intact
meniscus.
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the GFPþ synovial MSC tracking experiments, we used 10 million
MSCs instead of the 20 million MSCs transplanted in the other
experiments. These cells were readily detected without the need to
increase the dose to 20 million MSCs, as was the case in assays for
efﬁcacy. These data conﬁrmed the ability of MSCs to adhere to the
meniscus lesion.
In this study, allogeneic synovial MSCs were used. Though we
did not use immunosuppressive drugs to reduce the risk of infec-
tion, we did not observe obvious signs of immunoreaction in any of
the recipient pigs. When we injected allogeneic synovial MSCs into
the knee after the anterior half of themedial meniscuswas resected
in rabbits16, and pigs17, obvious immunoreactions were similarly
absent. These data suggest that the transplantation of allogeneic
synovial MSCs into the knee is a safe procedure. In human clinical
practice, allogeneic synovial MSCs have not yet been employed,
though allogeneic bone marrow MSCs have been used. Vangsness
et al. reported that intraarticular injections of allogenic bone
marrow MSCs to patients after partial meniscectomy did not cause
serious adverse events including immunological reaction in a
clinical study40.In terms of clinical implications, we propose three limitations to
the current study. First, we transplanted synovial MSCs immedi-
ately after we produced a meniscus lesion. In a clinical situation,
patients requiring cell therapy will have a degenerated meniscus
that will have been injured for what could be a long time after their
initial meniscus injury event. Ruiz-Iban et al. reported that the ef-
fect of MSCs on meniscal lesion was different between acute and
chronic lesions29. Investigations into whether synovial MSCs are
also effective in the repair of chronic lesions will be the subject of
our future work. Second, we did not follow the healing outcomes
after meniscal repair more than 12 weeks. Though transplantation
of synovial MSCs signiﬁcantly improved the healing of the
meniscus at 12 weeks, the repaired meniscus appeared to be less
than fullymature bothmorphologically and biomechanically. Third,
the number of animals sampled in each experiment was relatively
low.
Despite these limitations, the present study provides evidence
that synovial MSCs have the possibility to enhance healing of
meniscal repair. Therefore, the combination of synovial MSC cell
therapy and surgical suture repair can increase the indication for
clinical repair of meniscus injuries. This may contribute to
increasing the chance of saving a patient’smeniscus, preventing the
development of osteoarthritis in patients with meniscus injuries.
In conclusion, the transplantation of synovial MSCs promoted
healing of meniscal repair with the induction of synovium into the
longitudinal tear in the avascular zone in the microminipig
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Fig. 6. Distribution of transplanted MSCs. (A) Macroscopic features. The sutured meniscus was immersed with synovial MSC suspension for 10 min, the knee was ﬂexed and
extended 100 times, and then the meniscus with tibial plateau was photographed. (B) Synovial MSCs taking up particles of ferucarbotran indicated with arrow heads. (C) Fer-
ucarbotran are visualized as scattered black dots in MRI. Synovial MSCs labeled with ferucarbotran are indicated with arrows.
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